Inceptor Bio
PrivateLast Round
Series A
Extension
Feb 25, 2025
Total Funding Raised
$84M
Company Overview
Inceptor Bio operates in Healthcare & Life Sciences and is based in Morrisville, North Carolina. Its latest recorded funding round was a Series A Extension round in February 2025.
Inceptor Bio is a biotechnology company that develops next-generation cell and gene therapies to treat difficult-to-treat cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inceptor Bio Comparables
Compare Inceptor Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| FastBack Bio | 88% | |
| Link Cell Therapies | 88% | |
| Currus Biologics | 86% |
For institutional investors. Book with your work email.
Inceptor Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Feb 25, 2025 | ||||
| Series A | May 19, 2022 | ||||
| Seed | Jun 14, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Inceptor Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kineticos Ventures | Series A, Seed, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors increased 71% MoM, reaching 3.5K.
- Nov 3, 2025
Data on IB-T101 candidate to be presented at 2025 SITC Annual Meeting.
For institutional investors. Book with your work email.
Inceptor Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Inceptor Bio's valuation, stock price, and market status.
Is Inceptor Bio a public or private company?
Inceptor Bio is a private company.
What is the current stock price of Inceptor Bio?
Inceptor Bio is a private company, so its shares have no public market price. Caplight tracks Inceptor Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Inceptor Bio worth (valuation)?
Valuation information for Inceptor Bio is not publicly available.
Can I buy Inceptor Bio stock?
Inceptor Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Inceptor Bio's last funding round?
Inceptor Bio's most recent funding round was Series A Extension on February 25, 2025.
Who are the main investors in Inceptor Bio?
Key investors in Inceptor Bio include Kineticos Ventures.
Will Inceptor Bio IPO soon?
No public IPO plans have been announced for Inceptor Bio.
How can I track Inceptor Bio secondary market activity?
Caplight tracks bids, offers, and trades in Inceptor Bio's shares on secondary markets.